siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.
about
PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer.Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han womenSilencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle GrowthSimultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cellsCyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies.MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cellsHigh expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cellsTargeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis.Cell Culture Models and Pharmacological Perspective for the Study of Breast Cancer MarkersHepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.17beta-estradiol induces both up-regulation and processing of cyclin E in a calpain-dependent manner in MCF-7 breast cancer cells.A database of breast oncogenic specific siRNAs.PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts.
P2860
Q33782728-B13D48D8-B385-4D10-83C4-4241BA68AC57Q34489947-72B42D5E-18DD-47B2-A8BE-2D40416A1A72Q34536058-16869FF1-82E4-4B4C-938E-FE27DDBA946EQ34953963-726EEC6B-F9D3-4C39-A239-5E2618D10C87Q35151182-EB74F104-F4A2-461E-9754-9F3C9EA3F354Q35585464-BD5DC7CF-AA9D-4C6A-9E0C-203DBBB2BE32Q35686653-F5F633A8-2608-4687-ADDC-518B1BD1C01AQ35955231-2A2AF273-68C2-4B44-A41B-C99BB54788A8Q36144711-50582F46-DAF5-4D19-9FA1-E5AE96119D7DQ36187728-EA916204-FE56-4477-877B-9DD75A78575FQ36544125-525ECFF0-F1B2-496D-AEC0-F228F7A870EEQ36674327-0F960042-4E8F-4CE4-BCE9-F3509AE31DE3Q37071327-6E3274A3-5DC2-470F-B558-2A0AF765916EQ37155008-B5578587-A464-43A6-BD73-644680B8E361Q37382521-0B96EEC4-111E-487A-8626-F54745FD22A8Q39373705-631364EB-C3CB-411D-8B20-BEAA3E994723Q41459105-C732F86C-25C4-417D-BC81-F0EE1078E157Q47271622-003C2A19-3882-4CA1-ACD2-74B923756217Q53091886-873A0FAF-D225-4174-9A5F-D16F7F4C2B7C
P2860
siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@ast
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@en
type
label
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@ast
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@en
prefLabel
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@ast
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@en
P2093
P2860
P1433
P1476
siRNA-based targeting of cycli ...... in breast cancer mouse model.
@en
P2093
Francis C Brunicardi
John A Goss
Shiaw-Yih Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0012860
P407
P50
P577
2010-09-20T00:00:00Z